1999
DOI: 10.1046/j.1365-2222.1999.00519.x
|View full text |Cite
|
Sign up to set email alerts
|

Salbutamol pretreatment does not change eosinophil percentage and eosinophilic cationic protein concentration in hypertonic saline‐induced sputum in asthmatic subjects

Abstract: Salbutamol pretreatment reduces the severity of bronchoconstriction induced by HS inhalation without significantly affecting the percentages of inflammatory cells and the levels of soluble mediators in induced sputum.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
1
3

Year Published

2002
2002
2012
2012

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(22 citation statements)
references
References 22 publications
1
17
1
3
Order By: Relevance
“…2-4 puffs from a standard metered-dose inhaler, has generally been used for pretreatment. Pretreatment with high doses of salbutamol has not been universally effective in preventing hypertonic saline-induced bronchoconstriction [12,[15][16][17]. In addition, subsequent bronchospasm may be more severe or more difficult to reverse.…”
Section: Bronchodilator Pretreatmentmentioning
confidence: 99%
“…2-4 puffs from a standard metered-dose inhaler, has generally been used for pretreatment. Pretreatment with high doses of salbutamol has not been universally effective in preventing hypertonic saline-induced bronchoconstriction [12,[15][16][17]. In addition, subsequent bronchospasm may be more severe or more difficult to reverse.…”
Section: Bronchodilator Pretreatmentmentioning
confidence: 99%
“…Therefore, a single dose of salbutamol 200 μg is recommended both before and after the measurement of FEV 1 for 10 min. Salbutamol pretreatment does not interfere the inflammatory cell percentage in induced sputum (Cianchetti et al 1999. Regarding the effects on soluble mediators in sputum supernatant, salbutamol has no effect on eosinophil cationic protein (ECP) levels, but tends to reduce histamine concentrations (Cianchetti et al 1999).…”
Section: Sputum Inductionmentioning
confidence: 99%
“…Salbutamol pretreatment does not interfere the inflammatory cell percentage in induced sputum (Cianchetti et al 1999. Regarding the effects on soluble mediators in sputum supernatant, salbutamol has no effect on eosinophil cationic protein (ECP) levels, but tends to reduce histamine concentrations (Cianchetti et al 1999). There has been no study for the effect of salbutamol on the levels of other soluble mediators (i.e., cytokines, albumin, and neutrophil elastase) or the expression of cell activation markers as detected by immunocytochemistry.…”
Section: Sputum Inductionmentioning
confidence: 99%
See 1 more Smart Citation
“…En effet, il a été montré que l'expectoration précoce (les 5 premières minutes) contient plus de granulocytes alors que l'expectoration tardive s'enrichit en cellules mononucléées [6] . Les solutions salines hypertoniques pouvant induire un bronchospasme sévère, il est conseillé de pré-traiter le patient avec des ␤2-mimétiques à courte durée d'action avant l'induction [7,8] . De plus, lorsque le volume maximal expiré en 1 seconde (VEMS) de base est inférieur à 65 %, il est préférable d'utiliser une solution saline isotonique [9] .…”
Section: Technique D'induction Et D'analyse De L'expectoration Induiteunclassified